Knockdown of CSRP2 significantly inhibited the invasion of breast cancers [62], the proliferation of desmoid tumors [64], and the migration and invasive ability of head and neck squamous cell carcinoma cells [65], and increased drug sensitivity in acute lymphoblastic leukemia [15]. Here, CSRP2 is linked to breast cancer.